Christian Kersten
Kristiansand, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Origin and evolution of colorectal mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN).
Journal: Endocrine-related cancer
Published: March 30, 2026
Origin and evolution of colorectal mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN).
Journal: Endocrine-related cancer
Published: March 30, 2026
Assessment of 16S rRNA sequencing for analysis of circulating microbial DNA in colorectal cancer patients-proof of concept and early changes during experimental chemoimmunotherapy.
Journal: Frontiers in microbiology
Published: February 02, 2026
Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.
Journal: ImmunoTargets and therapy
Published: January 09, 2026
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer.
Journal: British journal of cancer
Published: August 13, 2025
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.
Journal: British journal of cancer
Published: July 14, 2025
Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.
Journal: British journal of cancer
Published: January 27, 2025
Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade.
Journal: Oncoimmunology
Published: July 02, 2024
Circulating Levels of the Proinflammatory Monomeric Isoform of C-Reactive Protein (mCRP) Correlate with Intra-Tumoral mCRP Abundance in Stage II-III Colon Cancer Patients.
Journal: Journal of inflammation research
Published: July 01, 2024
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms.
Journal: British journal of cancer
Published: December 20, 2023
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial.
Journal: British journal of cancer
Published: December 14, 2023
Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.
Journal: Endocrine-related cancer
Published: March 06, 2023
Last Updated: 09/26/2026